HNL.DE
Dr. Hönle AG [HNL.DE] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HNL.DE Stock Summary
Top 10 Correlated ETFs
HNL.DE
Top 10 Correlated Stocks
HNL.DE
In the News
HNL.DE Financial details
Company Rating
Sell
Market Cap
121.84M
Income
-13.83M
Revenue
102.51M
Book val./share
15.38
Cash/share
1.41
Dividend
-
Dividend %
-
Employees
581
Optionable
No
Shortable
Yes
Earnings
22 Feb 2024
P/E
-4.26
Forward P/E
-
PEG
-9.29
P/S
0.94
P/B
1.05
P/C
14.11
P/FCF
-18.36
Quick Ratio
0.83
Current Ratio
2.11
Debt / Equity
0.58
LT Debt / Equity
0.44
-
-
EPS (TTM)
-2.28
EPS next Y
-
EPS next Q
-
EPS this Y
-16.51%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-0.26%
Revenue Q/Q
-10.58%
EPS Q/Q
-79.17%
-
-
-
-
SMA20
10.12%
SMA50
19.01%
SMA100
11.34%
Inst Own
-
Inst Trans
-
ROA
-14%
ROE
-23%
ROC
-0.18%
Gross Margin
40%
Oper. Margin
-24%
Profit Margin
-22%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
15.0-24.5
52W High
-17.08%
52W Low
+32.67%
RSI
59.2
Rel Volume
4
Avg Volume
4.41K
Volume
17.64K
Perf Week
-1%
Perf Month
10.56%
Perf Quarter
13.07%
Perf Half Y
18.45%
-
-
-
-
Beta
1.479
-
-
Volatility
0.13%, 0.87%
Prev Close
0.76%
Price
19.9
Change
-0.5%
HNL.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-09-30
| Metric | History | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 19.55 | 16.84 | 19 | 20.87 | 17.54 | |
| Net income per share | 2.26 | 1.02 | -0.8 | -2.18 | -1.82 | |
| Operating cash flow per share | 3.07 | 1.3 | 0.19 | -1.22 | 0.52 | |
| Free cash flow per share | -0.43 | -4.12 | -2.63 | -1.93 | 0.03 | |
| Cash per share | 2.26 | 5.69 | 1.6 | 0.12 | 0.3 | |
| Book value per share | 16.32 | 20.87 | 18.26 | 17.63 | 15.81 | |
| Tangible book value per share | 12.5 | 17.16 | 14.37 | 13.85 | 12.61 | |
| Share holders equity per share | 16.32 | 20.87 | 18.26 | 17.63 | 15.81 | |
| Interest debt per share | 3 | 8.41 | 9.04 | 10.07 | 9.68 | |
| Market cap | 274.21M | 309.88M | 247.63M | 87.78M | 108.81M | |
| Enterprise value | 276.03M | 322.12M | 289.19M | 140.17M | 156.38M | |
| P/E ratio | 21.98 | 54.58 | -50.95 | -6.65 | -9.89 | |
| Price to sales ratio | 2.54 | 3.3 | 2.15 | 0.69 | 1.02 | |
| POCF ratio | 16.2 | 42.84 | 219.14 | -11.85 | 34.62 | |
| PFCF ratio | -116.49 | -13.49 | -15.52 | -7.49 | 520.62 | |
| P/B Ratio | 3.05 | 2.66 | 2.24 | 0.82 | 1.14 | |
| PTB ratio | 3.05 | 2.66 | 2.24 | 0.82 | 1.14 | |
| EV to sales | 2.56 | 3.43 | 2.51 | 1.11 | 1.47 | |
| Enterprise value over EBITDA | 13.29 | 21.01 | 20.79 | 49.62 | 104.12 | |
| EV to operating cash flow | 16.31 | 44.53 | 255.92 | -18.93 | 49.76 | |
| EV to free cash flow | -117.26 | -14.03 | -18.12 | -11.97 | 748.25 | |
| Earnings yield | 0.05 | 0.02 | -0.02 | -0.15 | -0.1 | |
| Free cash flow yield | -0.01 | -0.07 | -0.06 | -0.13 | 0 | |
| Debt to equity | 0.18 | 0.4 | 0.48 | 0.56 | 0.59 | |
| Debt to assets | 0.11 | 0.24 | 0.26 | 0.3 | 0.32 | |
| Net debt to EBITDA | 0.09 | 0.8 | 2.99 | 18.55 | 31.67 | |
| Current ratio | 3.02 | 4.18 | 2.95 | 1.58 | 2.04 | |
| Interest coverage | 104.96 | 17.72 | 0.3 | -7.62 | -5.19 | |
| Income quality | 1 | 0.92 | -1.86 | 0.64 | -0.29 | |
| Dividend Yield | 0.02 | 0.01 | 0.01 | 0.01 | 0 | |
| Payout ratio | 0.35 | 0.78 | -0.62 | -0.09 | -0.01 | |
| Sales general and administrative to revenue | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | |
| Research and developement to revenue | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 | |
| Intangibles to total assets | 0.15 | 0.11 | 0.12 | 0.12 | 0.11 | |
| Capex to operating cash flow | -1.14 | -4.17 | -15.12 | 0.58 | -0.93 | |
| Capex to revenue | -0.18 | -0.32 | -0.15 | -0.03 | -0.03 | |
| Capex to depreciation | -5.82 | -4.57 | -1.27 | -0.3 | -0.3 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 28.83 | 21.87 | 18.15 | 29.39 | 25.41 | |
| ROIC | 0.12 | 0.03 | 0.02 | -0.08 | -0.06 | |
| Return on tangible assets | 0.1 | 0.03 | -0.03 | -0.08 | -0.07 | |
| Graham Net | -1.54 | -3.08 | -6.85 | -7.39 | -7.37 | |
| Working capital | 47.69M | 66.95M | 53.95M | 29.63M | 33.68M | |
| Tangible asset value | 68.92M | 95.66M | 87.12M | 83.99M | 76.43M | |
| Net current asset value | 17.3M | 8.51M | -10.18M | -7.57M | -14.09M | |
| Invested capital | 0.18 | 0.4 | 0.48 | 0.56 | 0.59 | |
| Average receivables | 22.58M | 18.8M | 20.75M | 25.2M | 23.91M | |
| Average payables | 7.35M | 7.18M | 7.96M | 9.86M | 8.93M | |
| Average inventory | 34.55M | 35.51M | 40.08M | 45.5M | 40.38M | |
| Days sales outstanding | 68.39 | 67.7 | 76.36 | 75.87 | 73.84 | |
| Days payables outstanding | 82.21 | 71.02 | 75.12 | 58.49 | 52.06 | |
| Days of inventory on hand | 374.91 | 384.91 | 358.45 | 261.32 | 239.46 | |
| Receivables turnover | 5.34 | 5.39 | 4.78 | 4.81 | 4.94 | |
| Payables turnover | 4.44 | 5.14 | 4.86 | 6.24 | 7.01 | |
| Inventory turnover | 0.97 | 0.95 | 1.02 | 1.4 | 1.52 | |
| ROE | 0.14 | 0.05 | -0.04 | -0.12 | -0.11 | |
| Capex per share | -3.5 | -5.42 | -2.82 | -0.71 | -0.48 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q1
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 4.56 | 4.27 | 4.33 | 4.39 | 3.92 | |
| Net income per share | 0.32 | 0.11 | -1.52 | -0.72 | -0.15 | |
| Operating cash flow per share | 0.43 | -0.4 | 0.13 | 0.36 | 0.28 | |
| Free cash flow per share | 0.21 | -0.45 | 0.05 | 0.23 | 0.25 | |
| Cash per share | 1.07 | 0.94 | 0.98 | 0.3 | 1.41 | |
| Book value per share | 17.88 | 17.93 | 16.39 | 15.81 | 15.38 | |
| Tangible book value per share | 14.06 | 14.07 | 12.55 | 12.61 | 12.2 | |
| Share holders equity per share | 17.88 | 17.93 | 16.39 | 15.81 | 15.38 | |
| Interest debt per share | 9.38 | 9.39 | 9.33 | 9.49 | 8.98 | |
| Market cap | 118.08M | 123.36M | 138.82M | 108.81M | 105.78M | |
| Enterprise value | 166.97M | 173.17M | 188.08M | 156.38M | 152.2M | |
| P/E ratio | 15.37 | 45.35 | -3.76 | -6.21 | -29.35 | |
| Price to sales ratio | 4.28 | 4.76 | 5.29 | 4.09 | 4.45 | |
| POCF ratio | 44.95 | -50.85 | 181.46 | 49.98 | 61.36 | |
| PFCF ratio | 94.02 | -44.76 | 437.91 | 78.17 | 70.29 | |
| P/B Ratio | 1.09 | 1.13 | 1.4 | 1.14 | 1.13 | |
| PTB ratio | 1.09 | 1.13 | 1.4 | 1.14 | 1.13 | |
| EV to sales | 6.05 | 6.69 | 7.17 | 5.88 | 6.4 | |
| Enterprise value over EBITDA | 42.6 | 55.36 | -20.77 | 44.5 | 233.8 | |
| EV to operating cash flow | 63.56 | -71.38 | 245.85 | 71.83 | 88.29 | |
| EV to free cash flow | 132.94 | -62.83 | 593.31 | 112.35 | 101.13 | |
| Earnings yield | 0.02 | 0.01 | -0.07 | -0.04 | -0.01 | |
| Free cash flow yield | 0.01 | -0.02 | 0 | 0.01 | 0.01 | |
| Debt to equity | 0.52 | 0.52 | 0.57 | 0.59 | 0.58 | |
| Debt to assets | 0.3 | 0.3 | 0.32 | 0.32 | 0.32 | |
| Net debt to EBITDA | 12.47 | 15.93 | -5.44 | 13.54 | 71.31 | |
| Current ratio | 1.77 | 2.55 | 2.11 | 2.04 | 2.19 | |
| Interest coverage | 5.8 | 3.57 | -28.18 | -3.91 | -1.47 | |
| Income quality | 1.12 | -2.37 | -0.07 | -0.63 | -1.91 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | -0.01 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.13 | 0.13 | 0.13 | 0.11 | 0.12 | |
| Capex to operating cash flow | -0.52 | 0.14 | -0.59 | -0.36 | -0.13 | |
| Capex to revenue | -0.05 | -0.01 | -0.02 | -0.03 | -0.01 | |
| Capex to depreciation | -0.92 | -0.2 | -0.31 | -0.15 | -0.16 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 11.29 | 6.73 | 23.69 | 16.03 | 7.17 | |
| ROIC | 0.01 | 0.01 | -0.06 | -0.02 | 0 | |
| Return on tangible assets | 0.01 | 0 | -0.06 | -0.03 | -0.01 | |
| Graham Net | -5.99 | -5.6 | -6.46 | -7.37 | -6.01 | |
| Working capital | 32.61M | 45.23M | 33.65M | 33.68M | 33.68M | |
| Tangible asset value | 85.24M | 85.31M | 76.07M | 76.43M | 73.94M | |
| Net current asset value | -3.98M | -2.99M | -13.48M | -14.09M | -12.43M | |
| Invested capital | 0.52 | 0.52 | 0.57 | 0.59 | 0.58 | |
| Average receivables | 22.31M | 18.74M | 19.19M | 20.37M | 18.65M | |
| Average payables | 8.91M | 6.99M | 6.67M | 7.22M | 7.05M | |
| Average inventory | 45.57M | 46.01M | 41.48M | 35.42M | 35.03M | |
| Days sales outstanding | 59.72 | 66.55 | 65.98 | 72.79 | 59.74 | |
| Days payables outstanding | 62.19 | 58.88 | 29.02 | 62.29 | 28.22 | |
| Days of inventory on hand | 373.26 | 427.56 | 152.27 | 286.52 | 152.13 | |
| Receivables turnover | 1.51 | 1.35 | 1.36 | 1.24 | 1.51 | |
| Payables turnover | 1.45 | 1.53 | 3.1 | 1.44 | 3.19 | |
| Inventory turnover | 0.24 | 0.21 | 0.59 | 0.31 | 0.59 | |
| ROE | 0.02 | 0.01 | -0.09 | -0.05 | -0.01 | |
| Capex per share | -0.23 | -0.05 | -0.07 | -0.13 | -0.04 |
HNL.DE Frequently Asked Questions
What is Dr. Hönle AG stock symbol ?
Dr. Hönle AG is a DE stock and trading under the symbol HNL.DE
What is Dr. Hönle AG stock quote today ?
Dr. Hönle AG stock price is $19.9 today.
Is Dr. Hönle AG stock public?
Yes, Dr. Hönle AG is a publicly traded company.
Company Profile
- Volume Average 4.41K
- Market Capitalization 121.84M
- Employee 581
- CEO Dr. Franz Richter
- Headquarters Munich,DE
- IPO Date 2001-01-24
-
Website
https://www.hoenle.de 
Dr. Hönle AG supplies industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, medical technology, optics and opto electronics, automotive, and glass processing. The Equipment & Systems segment engages in the drying of inks and coatings, curing of adhesives and plastics, disinfecting surfaces, and solar simulation. The Glass & Lamps segment offers quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries, as well as lamps for water disinfection, and the drying of coatings and adhesives. The company was founded in 1976 and is headquartered in Munich, Germany.
